{"count": 4, "results": [{"_id": "32140388", "pmid": 32140388, "pmcid": "PMC7049637", "title": "Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer", "journal": "Acta Pharm Sin B", "authors": ["Ramakrishnan P", "Loh WM", "Gopinath SCB", "Bonam SR", "Fareez IM", "Mac Guad R", "Sim MS", "Wu YS"], "date": "2020-03-01T00:00:00Z", "doi": "10.1016/j.apsb.2019.11.008", "meta_date_publication": "2020 Mar", "meta_volume": "10", "meta_issue": "3", "meta_pages": "399-413", "score": 50262.49, "text_hl": "...@<m>DISEASE_Pancreatitis_Chronic</m> @DISEASE_MESH:D050500 @@@Chronic pancreatitis@@@", "citations": {"NLM": "Ramakrishnan P, Loh WM, Gopinath SCB, Bonam SR, Fareez IM, Mac Guad R, Sim MS, Wu YS. Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer Acta Pharm Sin B. 2020 Mar;10(3):399-413. PMID: 32140388", "BibTeX": "@article{32140388, title={Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer}, author={Ramakrishnan P and Loh WM and Gopinath SCB and Bonam SR and Fareez IM and Mac Guad R and Sim MS and Wu YS}, journal={Acta Pharm Sin B}, volume={10}, number={3}, pages={399-413}}"}}, {"_id": "34686769", "pmid": 34686769, "pmcid": "PMC8536656", "title": "Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis", "journal": "Sci Rep", "authors": ["Sung LC", "Chang CC", "Lin CS", "Yeh CC", "Cherng YG", "Chen TL", "Liao CC"], "date": "2021-10-22T00:00:00Z", "doi": "10.1038/s41598-021-99915-4", "meta_date_publication": "2021 Oct 22", "meta_volume": "11", "meta_issue": "1", "meta_pages": "20907", "score": 50239.453, "text_hl": "In conclusion, we reported that @SPECIES_9606 @@@patients@@@ with acute @<m>DISEASE_Pancreatitis_Chronic</m> @DISEASE_MESH:D050500 @@@or chronic pancreatitis@@@ were more likely to have acute @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@ASCVD@@@, particularly those with pancreas-related comorbidities, while the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is associated with a reduced risk of acute @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@ASCVD@@@. ", "citations": {"NLM": "Sung LC, Chang CC, Lin CS, Yeh CC, Cherng YG, Chen TL, Liao CC. Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis Sci Rep. 2021 Oct 22;11(1):20907. PMID: 34686769", "BibTeX": "@article{34686769, title={Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis}, author={Sung LC and Chang CC and Lin CS and Yeh CC and Cherng YG and Chen TL and Liao CC}, journal={Sci Rep}, volume={11}, number={1}, pages={20907}}"}}, {"_id": "28738823", "pmid": 28738823, "pmcid": "PMC5525317", "title": "Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer", "journal": "Mol Cancer", "authors": ["Chen K", "Qian W", "Jiang Z", "Cheng L", "Li J", "Sun L", "Zhou C", "Gao L", "Lei M", "Yan B", "Cao J", "Duan W", "Ma Q"], "date": "2017-07-24T00:00:00Z", "doi": "10.1186/s12943-017-0701-0", "meta_date_publication": "2017 Jul 24", "meta_volume": "16", "meta_issue": "1", "meta_pages": "131", "score": 50081.777, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ suppressed @<m>DISEASE_Pancreatitis_Chronic</m> @DISEASE_MESH:D050500 @@@chronic pancreatitis@@@-induced @DISEASE_Pancreatitis @DISEASE_MESH:D010195 @@@pancreatic tumorigenesis@@@", "citations": {"NLM": "Chen K, Qian W, Jiang Z, Cheng L, Li J, Sun L, Zhou C, Gao L, Lei M, Yan B, Cao J, Duan W, Ma Q. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer Mol Cancer. 2017 Jul 24;16(1):131. PMID: 28738823", "BibTeX": "@article{28738823, title={Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer}, author={Chen K and Qian W and Jiang Z and Cheng L and Li J and Sun L and Zhou C and Gao L and Lei M and Yan B and Cao J and Duan W and Ma Q}, journal={Mol Cancer}, volume={16}, number={1}, pages={131}}"}}, {"_id": "21757968", "pmid": 21757968, "title": "Pancreatogenic diabetes: special considerations for management.", "journal": "Pancreatology", "authors": ["Cui Y", "Andersen DK"], "date": "2011-01-01T00:00:00Z", "doi": "10.1159/000329188", "meta_date_publication": "2011", "meta_volume": "11", "meta_issue": "3", "meta_pages": "279-94", "score": 50040.637, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@ and insulin secretagogue treatment increases the risk of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@malignancy@@@, whereas @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy reduces it. ", "citations": {"NLM": "Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11(3):279-94. PMID: 21757968", "BibTeX": "@article{21757968, title={Pancreatogenic diabetes: special considerations for management.}, author={Cui Y and Andersen DK}, journal={Pancreatology}, volume={11}, number={3}, pages={279-94}}"}}]}